| FMIYX | VGTSX | FMIYX / VGTSX | |
| Total Expense Ratio | 0.80 | 0.17 | 471% |
| Annual Report Gross Expense Ratio | 0.80 | 0.17 | 471% |
| Fund Existence | 10 years | 30 years | - |
| Gain YTD | 0.428 | 14.603 | 3% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.98B | 629B | 0% |
| Annual Yield % from dividends | 4.33 | 2.56 | 169% |
| Returns for 1 year | -2.84 | 28.97 | -10% |
| Returns for 3 years | 15.12 | 59.34 | 25% |
| Returns for 5 years | 18.19 | 35.12 | 52% |
| Returns for 10 years | N/A | 103.97 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FLCH | 22.68 | 0.57 | +2.58% |
| Franklin FTSE China ETF | |||
| KMAR | 31.62 | 0.13 | +0.41% |
| Innovator U.S. Small Cp Pwr Buf ETF -Mar | |||
| FLQM | 56.80 | -0.25 | -0.44% |
| Franklin US Mid Cap Mltfctr Idx ETF | |||
| LRNZ | 63.53 | -0.50 | -0.78% |
| TrueShares Tech, AI and Deep Lrng ETF | |||
| THNR | 23.91 | -0.36 | -1.47% |
| Amplify Weight Loss Drug & Treatment ETF | |||